Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
Teva
Merck
US Department of Justice
Julphar
Daiichi Sankyo
Cerilliant
Moodys

Generated: July 17, 2018

DrugPatentWatch Database Preview

OMEGA-3-ACID ETHYL ESTERS - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for omega-3-acid ethyl esters and what is the scope of omega-3-acid ethyl esters patent protection?

Omega-3-acid ethyl esters
is the generic ingredient in three branded drugs marketed by Smithkline Beecham, Amneal Pharms, Apotex Inc, Par Pharm Inc, Strides Pharma, Teva Pharms Usa, and Osmotica, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for omega-3-acid ethyl esters. Twenty suppliers are listed for this compound.
Pharmacology for OMEGA-3-ACID ETHYL ESTERS

US Patents and Regulatory Information for OMEGA-3-ACID ETHYL ESTERS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms OMEGA-3-ACID ETHYL ESTERS omega-3-acid ethyl esters CAPSULE;ORAL 204940-001 Nov 27, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Osmotica OMTRYG omega-3-acid ethyl esters type a CAPSULE;ORAL 204977-001 Apr 23, 2014 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Strides Pharma OMEGA-3-ACID ETHYL ESTERS omega-3-acid ethyl esters CAPSULE;ORAL 203893-001 Sep 19, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa OMEGA-3-ACID ETHYL ESTERS omega-3-acid ethyl esters CAPSULE;ORAL 091028-001 Apr 7, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for OMEGA-3-ACID ETHYL ESTERS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham LOVAZA omega-3-acid ethyl esters CAPSULE;ORAL 021654-001 Nov 10, 2004 ➤ Sign Up ➤ Sign Up
Smithkline Beecham LOVAZA omega-3-acid ethyl esters CAPSULE;ORAL 021654-001 Nov 10, 2004 ➤ Sign Up ➤ Sign Up
Smithkline Beecham LOVAZA omega-3-acid ethyl esters CAPSULE;ORAL 021654-001 Nov 10, 2004 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
UBS
Johnson and Johnson
McKesson
Accenture
Daiichi Sankyo
Healthtrust
Cipla
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.